NASDAQ: GHDX       Genomic Health Inc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target: 20.00
Price Target Upside/Downside: +20.00


No recent Headlines for this stock.

Business Background

Genomic Health Inc provides genomic-based diagnostic tests that focus on the treatment of early-stage cancer. The firm’s Oncotype DX tests analyze the expression levels of genes in tumor tissue samples and provide a numeric score that physicians can use to determine the aggressiveness of breast, colon, or prostate cancer. These test results can guide decisions about the use of chemotherapy, radiation, surgery, or other aggressive treatments. The Oncotype DX breast cancer test generates the majority of the firm’s revenue, analyzing 21 genes to determine the optimal treatment for stage I, II, or IIa breast cancer. The majority of Genomic Health’s sales occur within the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4384  2018  242  3249 

Top 10 Active Counters
 AMC 3.51+0.53 
 CTRM 0.405-0.02 
 ADMP 1.79+0.52 
 GME 65.01+21.98 
 AZRX 1.84+0.60 
 SNDL 0.645-0.016 
 LK 1.38+1.38 
 PLTR 32.58+6.60 
 NIO 61.95+3.61 
 MKD 1.53+0.642